U.S. flag

An official website of the United States government

NM_001204.7(BMPR2):c.1039T>C (p.Cys347Arg) AND Primary pulmonary hypertension

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 29, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001360167.5

Allele description [Variation Report for NM_001204.7(BMPR2):c.1039T>C (p.Cys347Arg)]

NM_001204.7(BMPR2):c.1039T>C (p.Cys347Arg)

Gene:
BMPR2:bone morphogenetic protein receptor type 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q33.2
Genomic location:
Preferred name:
NM_001204.7(BMPR2):c.1039T>C (p.Cys347Arg)
HGVS:
  • NC_000002.12:g.202530865T>C
  • NG_009363.1:g.159539T>C
  • NM_001204.7:c.1039T>CMANE SELECT
  • NP_001195.2:p.Cys347Arg
  • LRG_712t1:c.1039T>C
  • LRG_712:g.159539T>C
  • NC_000002.11:g.203395588T>C
  • NM_001204.6:c.1039T>C
Protein change:
C347R
Links:
dbSNP: rs1085307290
NCBI 1000 Genomes Browser:
rs1085307290
Molecular consequence:
  • NM_001204.7:c.1039T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Primary pulmonary hypertension (PPH1)
Identifiers:
MONDO: MONDO:0001999; MedGen: C0152171

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001556070Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 29, 2022)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension.

Rudarakanchana N, Flanagan JA, Chen H, Upton PD, Machado R, Patel D, Trembath RC, Morrell NW.

Hum Mol Genet. 2002 Jun 15;11(13):1517-25.

PubMed [citation]
PMID:
12045205

Sequencing of mutations in the serine/threonine kinase domain of the bone morphogenetic protein receptor type 2 gene causing pulmonary arterial hypertension.

Mutlu Z, Kayıkçıoğlu M, Nalbantgil S, Vuran Ö, Kemal H, Moğulkoç N, Ertürk B, Onay H, Eroğlu Z, Kültürsay H.

Anatol J Cardiol. 2016 Jul;16(7):491-496. doi: 10.5152/AnatolJCardiol.2015.6297. Epub 2015 Sep 15.

PubMed [citation]
PMID:
26645265
PMCID:
PMC5331396
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001556070.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces cysteine, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 347 of the BMPR2 protein (p.Cys347Arg). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Cys347 amino acid residue in BMPR2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12045205, 16429395, 26645265). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BMPR2 protein function. ClinVar contains an entry for this variant (Variation ID: 425865). This missense change has been observed in individuals with pulmonary arterial hypertension (PMID: 16429395, 32581362). This variant is not present in population databases (gnomAD no frequency).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024